Lyra Therapeutics, Inc. (LYRA)

NASDAQ: LYRA · IEX Real-Time Price · USD

5.19

-0.20 (-3.71%)

At close: Apr 19, 2024, 4:00 PM

5.44

+0.25 (4.82%)

After-hours: Apr 19, 2024, 5:37 PM EDT

Lyra Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-62.68	-55.28	-43.51	-22.13	-16.31	-6.03
Depreciation & Amortization	0.28	1.07	1	0.1	0.03	0.08
Share-Based Compensation	5.89	5.45	2.77	1.81	0.24	0.41
Other Operating Activities	-6.79	5.38	13.92	-0.92	2.28	-1.1
Operating Cash Flow	-63.3	-43.39	-25.82	-21.14	-13.75	-6.64
Capital Expenditures	-1.05	-0.16	-3.39	-1.78	-0.21	-0.04
Change in Investments	-11.54	-64.84	0	0	0	0
Investing Cash Flow	-12.58	-65.01	-3.39	-1.78	-0.21	-0.04
Share Issuance / Repurchase	69.35	100.5	0.6	57.52	-0.12	0.01
Debt Issued / Paid	0	0	0	0	0	0.5
Other Financing Activities	-3.65	-4.25	-0.25	30.19	-	28.7
Financing Cash Flow	65.69	96.26	0.36	87.7	-0.12	29.21
Net Cash Flow	-10.2	-12.13	-28.85	64.79	-14.08	22.54
Free Cash Flow	-64.35	-43.55	-29.21	-22.92	-13.97	-6.68
Free Cash Flow Margin	-4130.36%	-3195.08%	-10247.37%	-	-	-536.74%
Free Cash Flow Per Share	-1.29	-1.44	-2.25	-2.67	-69.10	-40.20

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).